University of North Carolina School of Medicine Chapel Hill, North Carolina
This session will review the existing evidence supporting combination therapy in the treatment of Crohn's disease and ulcerative colitis. We will also review situations where combination therapy is not indicated and evaluate emerging literature on new combinations of approved therapies for the treatment of inflammatory bowel disease.
Learning Objectives:
To understand the evidence for use of combination therapy in the treatment of Crohn’s disease and ulcerative colitis
To discuss situations where combination therapy is not indicated
To evaluate emerging literature on new combinations of FDA approved therapies for the treatment of inflammatory bowel disease